Skip to main content
. 2021 Apr 26;95(10):e01819-20. doi: 10.1128/JVI.01819-20

FIG 3.

FIG 3

Antiviral SARS-CoV-2 activity and cytotoxicity of PF-00835231 and GC-376 in A549+ACE2 cells. Antiviral assay workflow as described in Fig. 2a. (a) PF-00835231 and (b) GC-376 antiviral activity and cytotoxicity in A549+ACE2 cells infected with SARS-CoV-2 USA-WA1/2020 for 24 h. Representative graphs are shown. (c) PF-00835231 and (d) GC-376 antiviral activity and cytotoxicity in A549+ACE2 cells infected with SARS-CoV-2 USA/NYU-VC-003/2020 for 24 h. Representative graphs are shown. (e) Representative images of SARS-CoV-2 USA-WA1/2020 syncytium formation at 48 hpi in A549+ACE2 cells under treatment with 1 μM PF-00835231 or GC-376.